| abstract |
ThenThe invention relates to specific antibodies, in particular an antibody specificallynagainst the leptin binding protein, as well as the use of this antibodynquantitative analysis, in selected indications for therapeuticnPurposes and for the production of therapeutics. The invention relatesnFurthermore, a method for the quantitative determination of leptin innthe sample dissolvednor suspended binding proteins using specificnantibodynand diagnostics and (diagnostic) kits containing this antibody. |